Physician

Emily Whitman-Purves, M.D.

According to 2025 Medicare claims, Emily Whitman-Purves, M.D. (NPI: 1891012738) practices hematology/oncology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 43219-1530.

Whitman-Purves' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 255 traditional Medicare patients, billed 83,852 HCPCS/CPT codes, and received $1,875,863 in Medicare payments. The top billing code was 74177 (Ct scan of abdomen and pelvis with contrast). Part D data shows 1,140 prescription claims across 258 beneficiaries totaling $2,465,455 in drug costs, led by Ibrance (Palbociclib). Open Payments data shows 45 records totaling $94,257. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $38,613 to $1,875,863. Similarly, Part D prescription costs have risen steadily, from $430 to $2,465,455. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	31	1,822	$38,613
2017	233	40,150	$446,632
2018	248	44,506	$544,286
2019	255	47,122	$845,547
2020	251	77,354	$1,060,016
2021	271	88,413	$1,464,641
2022	325	98,258	$2,130,808
2023	320	122,877	$2,390,286
2024	255	83,852	$1,875,863

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	15	$430
2016	12	16	$20,543
2017	106	348	$289,440
2018	134	566	$557,442
2019	145	583	$951,992
2020	185	958	$1,297,601
2021	214	968	$1,517,072
2022	226	1,037	$1,411,222
2023	266	1,069	$1,585,647
2024	258	1,140	$2,465,455

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
74177	Ct scan of abdomen and pelvis with contrast	34	73	$148
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	145	392	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	44	48	$50
36415	Insertion of needle into vein for collection of blood sample	127	413	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	127	541	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	53	1,477	$800,817
Lynparza	Olaparib	27	810	$289,592
Verzenio	Abemaciclib	16	448	$238,885
Brukinsa	Zanubrutinib	18	540	$215,450
Calquence	Acalabrutinib Maleate	12	360	$185,578

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$1,310	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	15	$92,948	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Emily Whitman-Purves, M.D.?

Tedicare shows public-source Medicare data for Emily Whitman-Purves, M.D. (NPI 1891012738), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emily Whitman-Purves, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Emily Whitman-Purves, M.D.?

Emily Whitman-Purves, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Emily Whitman-Purves, M.D. have Open Payments data?

Emily Whitman-Purves, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.